These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12417430)

  • 1. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization.
    Bedoui S; Lechner S; Gebhardt T; Nave H; Beck-Sickinger AG; Straub RH; Pabst R; von Hörsten S
    J Neuroimmunol; 2002 Nov; 132(1-2):25-33. PubMed ID: 12417430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes.
    Bedoui S; Kuhlmann S; Nave H; Drube J; Pabst R; von Hörsten S
    J Neuroimmunol; 2001 Jul; 117(1-2):125-32. PubMed ID: 11431012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
    J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation.
    Nave H; Bedoui S; Moenter F; Steffens J; Felies M; Gebhardt T; Straub RH; Pabst R; Dimitrijevic M; Stanojevic S; von Hörsten S
    J Neuroimmunol; 2004 Oct; 155(1-2):1-12. PubMed ID: 15342191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
    Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
    Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Induces Neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures.
    Hill JW; Urban JH; Xu M; Levine JE
    Endocrinology; 2004 May; 145(5):2283-90. PubMed ID: 14726443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
    Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
    J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels.
    Stadler J; Le TP; Haas P; Nave H
    Ann Anat; 2011 Dec; 193(6):486-93. PubMed ID: 22074679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen.
    von Hörsten S; Exton NG; Exton MS; Helfritz F; Nave H; Ballof J; Stalp M; Pabst R
    Brain Res; 1998 Sep; 806(2):282-6. PubMed ID: 9739152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors.
    Mitić K; Stanojević S; Kuštrimović N; Vujić V; Dimitrijević M
    Peptides; 2011 Aug; 32(8):1626-33. PubMed ID: 21699939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
    Nilsson T; Lind H; Brunkvall J; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
    Nilsson T; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between alpha 2-adrenergic and NPY receptor pathways in human erythroleukemia cells.
    Motulsky HJ; Michel MC
    Clin Exp Hypertens A; 1989; 11 Suppl 1():281-6. PubMed ID: 2545382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system.
    Han R; Kitlinska JB; Munday WR; Gallicano GI; Zukowska Z
    PLoS One; 2012; 7(5):e36609. PubMed ID: 22570731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
    Reubi JC; Gugger M; Waser B; Schaer JC
    Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.